Drug intelligence / Profile preview

TPX-112

Development stage: Preclinical
Lead developer: Tego Science
Modality: Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration: Topical

Overview

TPX-112 is an autologous cell therapy being developed by Tego Science for the treatment of oral mucosal defects. The therapy utilizes cultured mucosal cells derived from the patient's own tissue, which are expanded ex vivo and subsequently transplanted back into the patient to facilitate tissue regeneration and wound healing. By using autologous cells, the treatment aims to provide a biocompatible solution for repairing oral tissue damage while minimizing the risk of immune rejection. TPX-112 is currently in the preclinical stage of development.

Other names: autologous cultured mucosal cells

Beyond the preview

Go deeper on TPX-112.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPX-112.

Explore the full profile